Advertisement

Neurocritical Care

, Volume 26, Issue 2, pp 267–272 | Cite as

A Practical Approach to Ketogenic Diet in the Pediatric Intensive Care Unit for Super-Refractory Status Epilepticus

  • Raquel Farias-Moeller
  • Luca Bartolini
  • Archana Pasupuleti
  • R. D. Brittany Cines
  • Amy Kao
  • Jessica L. Carpenter
Original Article

Abstract

Background

Super-refractory status epilepticus (SRSE) ensues when there is no improvement of seizure control in response to anesthetic therapy or seizure recurrence after reduction of anesthetic agents. There is no consensus on standard of care for SRSE. Ketogenic diet (KD) has reported success, but technical challenges exist including inability to feed patients, concomitant steroid use, acidotic states, and lack of dieticians with experience. The optimal protocol for KD is yet to be determined. We describe our approach to initiation of KD in the pediatric intensive care unit (PICU).

Methods

Patients with SRSE who had KD initiation in the PICU were identified. Data from the hospital course were supplemented by review of the electronic medical record.

Results

Nine children with SRSE who had KD initiated in the PICU were identified. Descriptive analysis was performed. Mean age was 5.4 years (SD 2.24). Median number of days to start KD from detection of seizures was 13 [interquartile range (IQR) 10–16]. Mean time to achieve ketosis was 4.2 days (SD 3.4). The median number of antiepileptic drugs (AEDs) trialed before KD was started was 4 [IQR 3–4], and the median number of continuous infusions was 2 [IQR 2–3]. After initiation of KD, most patients were weaned off anesthetic infusions by 1 week. Outcomes were variable.

Conclusions

We demonstrated the feasibility of a practical approach to initiation of KD for children with SRSE. These children were successfully weaned off continuous anesthetic infusions. Larger studies are needed to determine effectiveness, safety, and tolerability of KD in the management of SRSE as well as ease of implementation.

Keywords

Ketogenic diet Super-refractory status epilepticus FIRES 

Notes

Compliance with ethical standards

Conflict of interest

The authors have no potential conflicts of interest to disclose.

References

  1. 1.
    Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3–23.CrossRefPubMedGoogle Scholar
  2. 2.
    Tasker RC, Vitali SH. Continuous infusion, general anesthesia and other intensive care treatment for uncontrolled status epilepticus. Curr Opin Pediatr. 2014;26:682–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Wilkes R, Tasker RC. Pediatric intensive care treatment of uncontrolled status epilepticus. Crit Care Clin. 2013;29:239–57.CrossRefPubMedGoogle Scholar
  4. 4.
    Cowley LE, Morris CB, Maguire SA, Farewell DM, Kemp AM. Validation of a prediction tool for abusive head trauma. Pediatrics. 2015;136:290–8.CrossRefPubMedGoogle Scholar
  5. 5.
    O’Connor SE, Ream MA, Richardson C, et al. The ketogenic diet for the treatment of pediatric status epilepticus. Pediatr Neurol. 2014;50:101–3.CrossRefPubMedGoogle Scholar
  6. 6.
    Caraballo RH, Flesler S, Armeno M, et al. Ketogenic diet in pediatric patients with refractory focal status epilepticus. Epilepsy Res. 2014;108:1912–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Appavu B, Vanatta L, Condie J, Kerrigan JF, Jarrar R. Ketogenic diet treatment for pediatric super-refractory status epilepticus. Seizure. 2016;41:62–5.CrossRefPubMedGoogle Scholar
  8. 8.
    Kossoff EH. International consensus statement on clinical implementation of the ketogenic diet: agreement, flexibility, and controversy. Epilepsia. 2008;49(Suppl 8):11–3.CrossRefPubMedGoogle Scholar
  9. 9.
    Freeman J, Veggiotti P, Lanzi G, Tagliabue A, Perucca E. Institute of neurology ICMF. The ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Res. 2006;68:145–80.CrossRefPubMedGoogle Scholar
  10. 10.
    Lin JJ, Lin KL, Chan OW, Hsia SH, Wang HS, Group CS. Intravenous ketogenic diet therapy for treatment of the acute stage of super-refractory status epilepticus in a pediatric patient. Pediatr Neurol. 2015;52:442–5.CrossRefGoogle Scholar
  11. 11.
    Gasior M, Rogawski MA, Hartman AL. Neuroprotective and disease-modifying effects of the ketogenic diet. Behav Pharmacol. 2006;17:431–9.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Bodenant M, Moreau C, Sejourne C, et al. Interest of the ketogenic diet in a refractory status epilepticus in adults. Rev Neurol (Paris). 2008;164:194–9.CrossRefGoogle Scholar
  13. 13.
    Strzelczyk A, Reif PS, Bauer S, et al. Intravenous initiation and maintenance of ketogenic diet: proof of concept in super-refractory status epilepticus. Seizure. 2013;22:581–3.CrossRefPubMedGoogle Scholar
  14. 14.
    Gruppuso PA, Schwartz R. Hypoglycemia in children. Pediatr Rev. 1989;11:117–24.CrossRefPubMedGoogle Scholar
  15. 15.
    Chesney CR. The maintenance need for water in parenteral fluid therapy, by Malcolm A. Holliday, MD, and William E. Segar, MD, Pediatrics, 1957; 19: 823–832. Pediatrics. 1998;102:229–30.CrossRefPubMedGoogle Scholar
  16. 16.
    Baumeister FA, Oberhoffer R, Liebhaber GM, et al. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics. 2004;35:250–2.CrossRefPubMedGoogle Scholar
  17. 17.
    Kossoff EH, Nabbout R. Use of dietary therapy for status epilepticus. J Child Neurol. 2013;28:1049–51.CrossRefPubMedGoogle Scholar
  18. 18.
    Thakur KT, Probasco JC, Hocker SE, et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology. 2014;82:665–70.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Cobo NH, Sankar R, Murata KK, Sewak SL, Kezele MA, Matsumoto JH. The ketogenic diet as broad-spectrum treatment for super-refractory pediatric status epilepticus: challenges in implementation in the pediatric and neonatal intensive care units. J Child Neurol. 2015;30:259–66.CrossRefPubMedGoogle Scholar
  20. 20.
    Bansal S, Cramp L, Blalock D, Zelleke T, Carpenter J, Kao A. The ketogenic diet: initiation at goal calories versus gradual caloric advancement. Pediatr Neurol. 2014;50:26–30.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of Child Neurology, Pediatric Neurocritical CareChildren’s National Health SystemWashington DCUSA
  2. 2.Department of NutritionChildren’s National Health SystemWashington DCUSA

Personalised recommendations